Pathobiology of bovine leukemia virus.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 7889034)

Published in Vet Res on January 01, 1994

Authors

I Schwartz1, D Lévy

Author Affiliations

1: URA-INRA d'Immuno-Pathologie Cellulaire et Moléculaire, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.

Articles citing this

Bovine leukemia virus DNA in human breast tissue. Emerg Infect Dis (2014) 1.41

Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study. PLoS One (2015) 1.37

Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14

In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene. J Virol (1999) 0.97

Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep. J Virol (1998) 0.91

Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol (2013) 0.88

Animal models on HTLV-1 and related viruses: what did we learn? Front Microbiol (2012) 0.88

Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins. J Virol (1996) 0.85

Bovine Leukemia Virus Infection in Dairy Cattle: Effect on Serological Response to Immunization against J5 Escherichia coli Bacterin. Vet Med Int (2011) 0.85

Using a herd profile to determine age-specific prevalence of bovine leukemia virus in michigan dairy herds. Vet Med Int (2012) 0.82

Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells. Immun Inflamm Dis (2016) 0.80

Prevalence of bovine leukemia virus (BLV) infection in the northeast of Iran. Vet Res Forum (2014) 0.80

First Report of Bovine Leukemia Virus Infection in Yaks (Bos mutus) in China. Biomed Res Int (2016) 0.79

Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1. J Virol (1997) 0.79

Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads. Retrovirology (2009) 0.78

Unpasteurized milk consumption and subsequent risk of cancer. Cancer Causes Control (2008) 0.78

Purified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture. Can J Vet Res (2005) 0.78

Serological and molecular detection of bovine leukemia virus in cattle in Iraq. Emerg Microbes Infect (2016) 0.75

Effect of freezing treatment on colostrum to prevent the transmission of bovine leukemia virus. J Vet Med Sci (2013) 0.75

Iron and Ferritin Levels in the Serum and Milk of Bovine Leukemia Virus-Infected Dairy Cows. Front Vet Sci (2015) 0.75

Articles by these authors

Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev Med (1992) 0.90

Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor. J Immunol (1983) 0.87

A high-resolution 1H NMR approach for structure determination of membrane peptides and proteins in non-deuterated detergent: application to mastoparan X solubilized in n-octylglucoside. J Biomol NMR (1995) 0.85

Serologic evidence for bovine immunodeficiency virus infection in France. Vet Microbiol (1996) 0.80

[Clinical experience with traumatic retinal detachment of Quinze-Vingts]. Mod Probl Ophthalmol (1972) 0.80

Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study. Eye (Lond) (2011) 0.79

Recombinant bovine interferon-gamma enhances expression of class I and class II bovine lymphocyte antigens. Vet Immunol Immunopathol (1989) 0.79

Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product. J Leukoc Biol (1994) 0.79

[Complement-fixing antibody in cattle with persistant lymphocytosis. Preliminary results with French livestock]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.78

Chronic hypophosphatemia in kidney transplanted children and young adults. Adv Exp Med Biol (1980) 0.76

[Pseudokeratoconus and ocular rosacea]. J Fr Ophtalmol (2004) 0.75

[C-type virus particles in lymphocytes cultured from cows with persistant lymphocytosis. Preliminary results on French cattle stock]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.75

[The demographic future of the pharmacy profession (1990-2020)]. Cah Sociol Demogr Med (1992) 0.75

[Spastic dysphonia treated by hypnosis]. Rev Otoneuroophtalmol (1970) 0.75

[Study on the efficacy and tolerance of a new major analgesic of the benzomorphan series: pentazocine]. Presse Med (1967) 0.75

Bovine immunodeficiency virus and analogies with human immunodeficiency virus. Leukemia (1999) 0.75

Immunochemical characterization of major histocompatibility antigens in cattle. Immunogenetics (1982) 0.75

[Use of Cowan strain I of Staphylococcus aureus for radio-immunological determination of retrovirus proteins]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.75

Bovine immunodeficiency virus: facts and questions. Vet Res (1996) 0.75

[In and out-of-hospital cardiac arrest and echography: a review]. Ann Fr Anesth Reanim (2009) 0.75

Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin. Thromb Res (1983) 0.75

[Effects of long-term 1alpha-(OH) D3 therapy on the hyperparathyroidism of children on maintenance hemodialysis (proceedings) (author's transl)]. Ann Endocrinol (Paris) (1978) 0.75

[Budd-Chiari syndrome with thrombosis of the inferior vena cava. Treatment by mesenterico-innominate shunt]. Gastroenterol Clin Biol (1988) 0.75

[Quantitative study of the genetics of haptoglobin levels]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.75

[Side-effects of the curare-like agents]. Anesth Analg (Paris) (1974) 0.75

[Sonographic aspects of recurrent paralysis before and after functional rehabilitation]. Rev Otoneuroophtalmol (1966) 0.75

A novel BoLA class II molecule with a tissue distribution different from BoLA-DR or BoLA-DQ molecules. Vet Res (1995) 0.75

[Action of digoxin on systolic and diastolic time intervals. An echocardiographic study in infants]. Arch Mal Coeur Vaiss (1983) 0.75

[Feline immunodeficiency virus]. Vet Res (1993) 0.75

[Young physicians and their private practice]. Cah Sociol Demogr Med (2001) 0.75

[Effects of rubidomycin in chronic myeloid leukemia]. Pathol Biol (1967) 0.75